InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Lemoncat post# 323656

Tuesday, 09/15/2020 12:45:53 PM

Tuesday, September 15, 2020 12:45:53 PM

Post# of 403039
Again, you are wrong. The company has already publicized that it is advancing Brilacidin against Covid in a Phase 2 trial. That means humans, not animals. The reason (again) is that animal testing is primarily to determine safety. Efficacy results (positive or negative) for a particular drug in animals often does not translate to humans, so the “fruitless” testing would be if we did an animal trial. Thankfully, Leo is smart enough not to waste our money on “fruitless” animal testing.

Lemoncat said,

It's not necessary but it can save you a lot of money by avoiding a fruitless clinical trial if it fails to work in test animals.

The whole point of this thread was that we have not established any efficacy against COVID in any living creature. So we are not beyond the "mouse and hamster" stage with regard to efficacy.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News